Clindamycin Hydrochloride
- Product NDC
- 50090-4317
- 11-digit product format
- 500904317
- Labeler code
- 50090
- Product ID
- 50090-4317_8f818fc4-3150-4afd-81f0-4b5f928c649e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clindamycin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA065442
- Marketing category
- ANDA
- Marketing start
- 2009-08-26
- Marketing end
- 0000-00-00
- Substance
- CLINDAMYCIN HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50090-4317-0 | 50090431700 | 30 CAPSULE in 1 BOTTLE (50090-4317-0) | 30 capsule | 2019-05-29 | 0000-00-00 | No | No | Current |
| 50090-4317-1 | 50090431701 | 30 CAPSULE in 1 BOTTLE (50090-4317-1) | 30 capsule | 2019-05-29 | 0000-00-00 | No | No | Current |